AU1131200A - Cationic lipid-mediated enhancement of nucleic acid immunization of cats - Google Patents

Cationic lipid-mediated enhancement of nucleic acid immunization of cats

Info

Publication number
AU1131200A
AU1131200A AU11312/00A AU1131200A AU1131200A AU 1131200 A AU1131200 A AU 1131200A AU 11312/00 A AU11312/00 A AU 11312/00A AU 1131200 A AU1131200 A AU 1131200A AU 1131200 A AU1131200 A AU 1131200A
Authority
AU
Australia
Prior art keywords
cats
nucleic acid
cationic lipid
mediated enhancement
acid immunization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU11312/00A
Inventor
Joel R. Haynes
Dan T Stinchcomb
Ramani S. Wonderling
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Heska Corp
Original Assignee
Heska Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heska Corp filed Critical Heska Corp
Publication of AU1131200A publication Critical patent/AU1131200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
AU11312/00A 1998-10-23 1999-10-22 Cationic lipid-mediated enhancement of nucleic acid immunization of cats Abandoned AU1131200A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US10546998P 1998-10-23 1998-10-23
US60105469 1998-10-23
US12244699P 1999-03-02 1999-03-02
US60122446 1999-03-02
PCT/US1999/024769 WO2000024428A2 (en) 1998-10-23 1999-10-22 Cationic lipid-mediated enhancement of nucleic acid immunization of cats

Publications (1)

Publication Number Publication Date
AU1131200A true AU1131200A (en) 2000-05-15

Family

ID=26802619

Family Applications (1)

Application Number Title Priority Date Filing Date
AU11312/00A Abandoned AU1131200A (en) 1998-10-23 1999-10-22 Cationic lipid-mediated enhancement of nucleic acid immunization of cats

Country Status (2)

Country Link
AU (1) AU1131200A (en)
WO (1) WO2000024428A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU782154B2 (en) * 1999-06-10 2005-07-07 Boehringer Ingelheim Animal Health USA Inc. DNA vaccines for pets and sport animals

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772047B1 (en) 1997-12-05 2004-04-09 Ct Nat D Etudes Veterinaires E GENOMIC SEQUENCE AND POLYPEPTIDES OF CIRCOVIRUS ASSOCIATED WITH PIGLET LOSS DISEASE (MAP), APPLICATIONS TO DIAGNOSIS AND TO PREVENTION AND / OR TREATMENT OF INFECTION
US6943152B1 (en) 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
US7078388B2 (en) 2000-01-21 2006-07-18 Merial DNA vaccines for farm animals, in particular bovines and porcines
US6852705B2 (en) 2000-01-21 2005-02-08 Merial DNA vaccines for farm animals, in particular bovines and porcines
KR102319843B1 (en) 2013-09-25 2021-10-29 조에티스 서비시즈 엘엘씨 Pcv2b divergent vaccine composition and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4726946A (en) * 1980-07-30 1988-02-23 Norden Laboratories, Inc. Inactivated rabies vaccine for veterinary use
AU2234995A (en) * 1994-04-29 1995-11-29 Pharmacia & Upjohn Company Feline immunodeficiency virus vaccine
US6693086B1 (en) * 1998-06-25 2004-02-17 National Jewish Medical And Research Center Systemic immune activation method using nucleic acid-lipid complexes

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU782154B2 (en) * 1999-06-10 2005-07-07 Boehringer Ingelheim Animal Health USA Inc. DNA vaccines for pets and sport animals
AU782154C (en) * 1999-06-10 2006-02-09 Boehringer Ingelheim Animal Health USA Inc. DNA vaccines for pets and sport animals

Also Published As

Publication number Publication date
WO2000024428A2 (en) 2000-05-04
WO2000024428A3 (en) 2000-07-06

Similar Documents

Publication Publication Date Title
AU1444201A (en) Preparation of nucleic acid samples
AU4567499A (en) Novel mtbx protein and nucleic acid molecules and uses therefor
BR9809112B1 (en) process for preparation of clopidogrel.
HUP0103214A3 (en) Method of dna vaccination
AU6978198A (en) Cationic polymers for nucleic acid transfection
NO20015828L (en) Methods for Preparation of 5 'Nucleic Acid Protein Conjugates
AU1450699A (en) Methods of nucleic acid detection
AU1131200A (en) Cationic lipid-mediated enhancement of nucleic acid immunization of cats
AU1742600A (en) Identification of disease predictive nucleic acids
AU8234898A (en) Characterising nucleic acid
IL138216A0 (en) Novel fdrg protein and nucleic acid molecules and uses therefor
HUP0004577A3 (en) Novel class of nucleic acid cationic transfecting agents
AU9257998A (en) Method for enhancing the activity of an enzyme
GB9717932D0 (en) Estimation of nucleic acid
AU2180000A (en) Nucleic acid molecules of shrimp
AU6376698A (en) Improved nucleic acid assays
AU4684099A (en) Oligonucleotides for enhanced modulation of protein kinase expression
IT1290457B1 (en) PROCESS FOR THE PREPARATION OF TETRAAZAMACROCYCLES
AU2114799A (en) Enhancement of cardiac chronotropy
AU4826899A (en) Novel msp-5 protein and nucleic acid molecules and uses therefor
AU5312699A (en) Novel mp-7 protein and nucleic acid molecules and uses therefor
AUPQ439699A0 (en) Detection of nucleic acid fragments
AUPO717197A0 (en) Improved biosensor
IL130606A0 (en) An array of nucleic acid sequence
AU3952599A (en) Method of labelling nucleic acid

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase